These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22221767)

  • 1. Enzyme-linked immunosorbent serum assay specific for the 7S domain of Collagen Type IV (P4NP 7S): A marker related to the extracellular matrix remodeling during liver fibrogenesis.
    Leeming DJ; Nielsen MJ; Dai Y; Veidal SS; Vassiliadis E; Zhang C; He Y; Vainer B; Zheng Q; Karsdal MA
    Hepatol Res; 2012 May; 42(5):482-93. PubMed ID: 22221767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of systemic collagen type IV formation with survival among patients undergoing hemodialysis.
    Leeming DJ; Karsdal MA; Rasmussen LM; Scholze A; Tepel M
    PLoS One; 2013; 8(8):e71050. PubMed ID: 23990924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver fibrogenesis marker, 7S domain of collagen type IV in patients with acutely decompensated heart failure: Correlates, prognostic value and time course.
    Nagao K; Tamura A; Morimoto T; Shimamura K; Yukawa H; Ito H; Hayashi F; Makita T; Takemura G; Sato Y; Inada T; Kimura T; Tanaka M
    Int J Cardiol; 2017 Jun; 236():483-487. PubMed ID: 28109578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver fibrosis marker, 7S domain of collagen type IV, in patients with pre-capillary pulmonary hypertension.
    Yoshihisa A; Kimishima Y; Kiko T; Sato Y; Watanabe S; Kanno Y; Abe S; Miyata-Tatsumi M; Sato T; Suzuki S; Oikawa M; Kobayashi A; Yamaki T; Sugimoto K; Kunii H; Nakazato K; Suzuki H; Ishida T; Takeishi Y
    Int J Cardiol; 2018 May; 258():269-274. PubMed ID: 29428236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between the Liver Fibrosis Markers and Scores, and Hemodynamic Congestion Assessed by Peripheral Venous Pressure in Patients With Acute Heart Failure.
    Nagao K; Maruichi-Kawakami S; Aida K; Matsuto K; Imamoto K; Yukawa H; Kanazawa T; Kobayashi Y; Takahashi N; Ito H; Hayashi F; Inada T
    J Am Heart Assoc; 2023 Nov; 12(21):e030788. PubMed ID: 37929710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel marker for assessment of liver matrix remodeling: an enzyme-linked immunosorbent assay (ELISA) detecting a MMP generated type I collagen neo-epitope (C1M).
    Leeming Dj; He Y; Veidal S; Nguyen Q; Larsen D; Koizumi M; Segovia-Silvestre T; Zhang C; Zheng Q; Sun S; Cao Y; Barkholt V; Hägglund P; Bay-Jensen A; Qvist P; Karsdal M
    Biomarkers; 2011 Nov; 16(7):616-28. PubMed ID: 21988680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MMP mediated degradation of type VI collagen is highly associated with liver fibrosis--identification and validation of a novel biochemical marker assay.
    Veidal SS; Karsdal MA; Vassiliadis E; Nawrocki A; Larsen MR; Nguyen QH; Hägglund P; Luo Y; Zheng Q; Vainer B; Leeming DJ
    PLoS One; 2011; 6(9):e24753. PubMed ID: 21935455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neo-epitope specific PRO-C3 ELISA measures true formation of type III collagen associated with liver and muscle parameters.
    Nielsen MJ; Nedergaard AF; Sun S; Veidal SS; Larsen L; Zheng Q; Suetta C; Henriksen K; Christiansen C; Karsdal MA; Leeming DJ
    Am J Transl Res; 2013; 5(3):303-15. PubMed ID: 23634241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological detection of the type V collagen propeptide fragment, PVCP-1230, in connective tissue remodeling associated with liver fibrosis.
    Vassiliadis E; Veidal SS; Simonsen H; Larsen DV; Vainer B; Chen X; Zheng Q; Karsdal MA; Leeming DJ
    Biomarkers; 2011 Aug; 16(5):426-33. PubMed ID: 21612338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of collagen-derived peptides as markers of organ injury in patients with acute heart failure.
    Nagao K; Tamura A; Sato Y; Hata R; Kawase Y; Kadota K; Horie T; Sowa N; Nishiga M; Ono K; Inada T; Tanaka M
    Open Heart; 2020; 7(1):e001041. PubMed ID: 32341786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein fingerprinting of the extracellular matrix remodelling in a rat model of liver fibrosis--a serological evaluation.
    Leeming DJ; Byrjalsen I; Jiménez W; Christiansen C; Karsdal MA
    Liver Int; 2013 Mar; 33(3):439-47. PubMed ID: 23279004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between atrial fibrillation and a liver fibrogenesis marker in patients with acute heart failure.
    Miyamoto R; Nagao K; Matsuto K; Hata R; Kawase Y; Maruichi-Kawakami S; Aida K; Kadota K; Sato Y; Inada T
    Int J Cardiol; 2023 Mar; 374():51-57. PubMed ID: 36638918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined antiretroviral therapy attenuates hepatic extracellular matrix remodeling in HIV patients assessed by novel protein fingerprint markers.
    Leeming DJ; Anadol E; Schierwagen R; Karsdal MA; Byrjalsen I; Nielsen MJ; Schwarzer-Zander C; Boesecke C; Bendtsen F; Møller S; Strassburg CP; Spengler U; Krag A; Rockstroh J; Trebicka JK
    AIDS; 2014 Sep; 28(14):2081-90. PubMed ID: 25136933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating markers of collagen types I, III, and IV in patients with dilated cardiomyopathy: relationships with myocardial collagen expression.
    Nagao K; Inada T; Tamura A; Kajitani K; Shimamura K; Yukawa H; Aida K; Sowa N; Nishiga M; Horie T; Makita T; Ono K; Tanaka M
    ESC Heart Fail; 2018 Dec; 5(6):1044-1051. PubMed ID: 30273997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of proteolytic degradation of the basement membrane: a fragment of type IV collagen as a biochemical marker for liver fibrosis.
    Veidal SS; Karsdal MA; Nawrocki A; Larsen MR; Dai Y; Zheng Q; Hägglund P; Vainer B; Skjøt-Arkil H; Leeming DJ
    Fibrogenesis Tissue Repair; 2011 Oct; 4():22. PubMed ID: 21970406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of serum 7S collagen and type VI collagen levels for the diagnosis of hepatic fibrosis.
    Ji X; Li S; Kong X; Xu G; Chen J; Dai X
    Chin Med J (Engl); 1997 Mar; 110(3):198-201. PubMed ID: 9594340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biglycan fragmentation in pathologies associated with extracellular matrix remodeling by matrix metalloproteinases.
    Genovese F; Barascuk N; Larsen L; Larsen MR; Nawrocki A; Li Y; Zheng Q; Wang J; Veidal SS; Leeming DJ; Karsdal MA
    Fibrogenesis Tissue Repair; 2013 May; 6(1):9. PubMed ID: 23635022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MMP mediated degradation of type IV collagen alpha 1 and alpha 3 chains reflects basement membrane remodeling in experimental and clinical fibrosis--validation of two novel biomarker assays.
    Sand JM; Larsen L; Hogaboam C; Martinez F; Han M; Røssel Larsen M; Nawrocki A; Zheng Q; Karsdal MA; Leeming DJ
    PLoS One; 2013; 8(12):e84934. PubMed ID: 24376856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of serum 7S fragment of type IV collagen and serum central triple-helix of type IV collagen for assessment of liver fibrosis in patients with chronic viral liver disease.
    Murawaki Y; Ikuta Y; Koda M; Yamada S; Kawasaki H
    J Hepatol; 1996 Feb; 24(2):148-54. PubMed ID: 8907567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel assay for extracellular matrix remodeling associated with liver fibrosis: An enzyme-linked immunosorbent assay (ELISA) for a MMP-9 proteolytically revealed neo-epitope of type III collagen.
    Barascuk N; Veidal SS; Larsen L; Larsen DV; Larsen MR; Wang J; Zheng Q; Xing R; Cao Y; Rasmussen LM; Karsdal MA
    Clin Biochem; 2010 Jul; 43(10-11):899-904. PubMed ID: 20380828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.